Briefly discuss the management of the microvascular complications of diabetes mellitus.
10 marks · directive: Briefly discuss
The core of a good answer
Retinopathy, nephropathy and neuropathy share one foundation: good control of glucose (HbA1c around 7%), blood pressure and lipids with no smoking; on top of this, retinopathy needs regular retinal examination, laser photocoagulation, anti-VEGF or steroid injections or vitrectomy; nephropathy needs annual albuminuria testing, an ACE inhibitor or ARB and an SGLT2 inhibitor; neuropathy needs foot examination and care and drugs for pain (pregabalin, duloxetine, tricyclics).
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
In a 10-mark 'briefly discuss' the examiner wants the common principles and then complication-specific screening and treatment, without long pathophysiology.
Answer outline
Introduction
Microvascular complications result from chronic hyperglycaemia damaging the small vessels of the retina, kidney and nerves; better glucose control reduces them.
Common measures
- Glycaemic control with an HbA1c target around 7% (further lowering is not recommended for most patients because of hypoglycaemia); blood pressure control; statins; stop smoking.
Diabetic retinopathy
- Comprehensive eye examination at the diagnosis of type 2 diabetes, then regular review (every 6 to 12 months for mild to moderate non-proliferative disease); in pregnancy an eye examination before pregnancy, in each trimester and for a year after delivery.
- Mild to moderate non-proliferative retinopathy: risk factor control; fenofibrate reduces progression.
- Proliferative or severe non-proliferative retinopathy: panretinal laser photocoagulation; macular oedema: intravitreal anti-VEGF (preferred near the centre of the macula) or steroid injections; large vitreous haemorrhage: vitrectomy.
Diabetic nephropathy
- Annual urine albumin testing (a spot urine albumin-to-creatinine ratio can be used); albuminuria 30 to 299 mg/24 h is microalbuminuria, 300 or more macroalbuminuria.
- ACE inhibitor or ARB (only one agent), more intensive BP lowering (125 to 130/below 80), SGLT2 inhibitor; GLP-1 agonists also slow progression.
- Avoid nephrotoxic drugs such as NSAIDs, adjust the doses of kidney-cleared drugs; haemodialysis and kidney transplantation in end-stage kidney disease.
Diabetic neuropathy
- Foot examination: 128 Hz tuning fork (the most useful finding for large-fibre neuropathy) and 5.07 Semmes-Weinstein monofilament.
- Painful neuropathy: pregabalin, duloxetine or venlafaxine, tricyclics (amitriptyline), tapentadol; opioids such as tramadol as second or third line.
- Foot care: off-loading to prevent ulcers, well-fitting shoes, early treatment of infection; autonomic neuropathy: manage orthostatic hypotension, gastroparesis and bladder dysfunction.
Conclusion
Early screening and combined risk factor control prevent blindness, kidney failure and amputations, the main disabling outcomes of diabetes.
Facts to remember
- ADA advises a comprehensive eye examination at the time of type 2 diabetes diagnosis.
- Fenofibrate reduces progression of mild to moderate diabetic retinopathy.
- Albuminuria under 30 mg/24 h is normal, 30 to 299 is microalbuminuria and 300 or more is macroalbuminuria; ACE inhibitors or ARBs are core therapy, using only one agent.
- An HbA1c target of about 7% is linked to fewer microvascular complications.
- Decreased vibration perception to a 128 Hz tuning fork is the most useful examination finding for large-fibre neuropathy; the 5.07 Semmes-Weinstein monofilament is also used.